What Researchers Did
Researchers conducted a prospective controlled study of 68 elite Russian athletes with abnormal ECG T-wave changes, comparing normoxic barotherapy (mild hyperbaric air at 0.3 atm above ambient with 30% oxygen) alone, combined with external counterpulsation (EECP), or neither.
What They Found
ECG improvement was seen in 68% of the normoxic barotherapy group, 80% of the combined treatment group, and 57% of controls. The combined group also showed improved aerobic endurance. This study used normoxic barotherapy rather than standard high-pressure HBOT.
What This Means for Canadian Patients
This study examines a non-standard pressure therapy used in Russian sports medicine, which is distinct from HBOT protocols used in Canadian clinical settings. The findings are not directly applicable to standard HBOT practice in Canada.
Canadian Relevance
No direct Canadian connection identified. The treatment protocol described does not correspond to Canadian hyperbaric clinical standards.
Study Limitations
The study uses a non-standard treatment protocol not typical of clinical HBOT; the control group received metabolic drugs, making it difficult to isolate the effect of barotherapy.